• Grand Rounds contact:
    grandrounds@dshs.texas.gov


    Continuing Education contact:
    ce.service@dshs.texas.gov 

     

Grand Rounds Home

GRAND ROUNDS:

Encouraging a Culture of Learning and the Integration of Evidence into Practice

E-mail updates

Fall 2020 Semester


Presentations are held on Wednesdays from 11:00 a.m. to 12:30 p.m. CT via webinar.

October 28: Addressing Substance Use in the Time of COVID-19
November 18: Vaping




 *"live" = not recorded 





Addressing Substance Use in the Time of COVID-19


Presenter:
Jennifer Sharpe Potter, PhD, MPH
Professor, Dept. of Psychiatry, School of Medicine, University of Texas Health Science Center - San Antonio

Description
The COVID-19 pandemic has major implications for substance use and substance use disorder. The presentation will provide a review of recent literature regarding the impact of COVID-19 on substance use disorder prevalence, novel approaches to addressing substance use disorder during COVID-19, and potential solutions to maintain access to high quality evidence-based care in Texas.

Learning Objectives:
State the prevalence of substance use and SUD sequelae in 2020.

Explain how the SUD treatment system is adapting to provide services during the pandemic

Identify possible approaches to address current and future challenges for addressing substance use in Texas during the pandemic.

1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only):

  • AMA PRA Category 1 CreditsTM
  • Continuing Nursing Education
  • Certified Health Education Specialists & Master-Certified Health Education Specialists
  • Certified in Public Health
  • Licensed Chemical Dependency Counselors
  • Licensed Marriage and Family Therapists 
  • Licensed Professional Counselors
  • Licensed Psychologists 
  • Registered Sanitarians
  • Social Workers

A certificate of attendance is available for those not seeking the credits/contact hours listed above.

Suggested Resources

Drake C, Yu J, Lurie N, Kraemer K, Polsky D, Chaiyachati KH. Policies to improve substance use disorder treatment with telehealth during the COVID-19 pandemic and beyond. J Addict Med. 2020;14(5):e139-e141.

Finley EP, Schneegans S, Curtis ME, et al. Confronting challenges to opioid risk mitigation in the U.S. health system: Recommendations from a panel of national experts. PLoS One. 2020;15(6):e0234425. Published 2020 Jun 15.

Jenkins WD, Bolinski R, Bresett J, et al. COVID-19 during the opioid epidemic: Exacerbation of stigma and vulnerabilities [published online ahead of print, 2020 Apr 11]. J Rural Health. 2020;10.

Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States [published online ahead of print, 2020 Sep 14] [published correction appears in Mol Psychiatry. 2020 Sep 30;:]. Mol Psychiatry. 2020;1-10.

[top of page]

 





Vaping


Presenters:
Jennifer Cofer, MPH
Director, EndTobacco Program & Cancer Prevention Policy, MD Anderson Cancer Center
Maria Cooper, PhD 

Manager, Chronic Disease Epidemiology Branch, TX Dept of State Health Services
Philip Huang, MD, MPH

Director, Dallas County Health Department
Kellen Kruk

Student Ambassador, Texas Say What! Texas State University

Description
The Texas Department of State Health Services identifies that the rapid increase in youth vaping prevalence is alarming; especially for public health professionals, teachers, parents, and peers.  The prevalence of youth e-cigarette use in Texas rose from 3.1% in 2012 to 13.0% in 2018; a significant increase among teens that has been linked to the increased popularity of USB-like flavored pod-based vaping devices. 

The distinguished panel will discuss the epidemiology of vaping, health risks, student perceptions, recent legislation and prevention/intervention strategies for communities and the state.

Learning Objectives:
Analyze the historical epidemiology of vaping and the outbreaks of e-cigarette, or vaping, product use-associated lung injury (EVALI).

Discuss the impact of COVID-19 on vaping.

Discuss the perspectives, and engagement, of Texas youth on vaping

Describe Texas’ community-based and statewide tobacco prevention and control strategies to address vaping.

1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only):

  • AMA PRA Category 1 CreditsTM
  • Continuing Nursing Education
  • Certified Health Education Specialists & Master-Certified Health Education Specialists
  • Certified in Public Health
  • Licensed Chemical Dependency Counselors
  • Licensed Marriage and Family Therapists 
  • Licensed Professional Counselors
  • Licensed Psychologists 
  • Registered Sanitarians
  • Social Workers

A certificate of attendance is available for those not seeking the credits/contact hours listed above.

Suggested Resources

Adkins SH, Anderson KN, Goodman AB, et al. Demographics, substance use behaviors, and clinical characteristics of adolescents with e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States in 2019. JAMA Pediatr. 2020;174(7):e200756.

Case KR, Mantey DS, Creamer MR, Harrell MB, Kelder SH, Perry CL. E-cigarette- specific symptoms of nicotine dependence among Texas adolescents. Addict Behav. 2018;84:57-61.

Jonas AM, Raj R. Vaping-related acute parenchymal lung injury: A systematic review. Chest. 2020;158(4):1555-1565.

Klemperer EM, West JC, Peasley-Miklus C, Villanti AC. Change in tobacco and eectronic cigarette use and motivation to quit in response to COVID-19. Nicotine Tob Res. 2020;22(9):1662-1663.

[top of page]


 




[top of page]

 
 




[top of page]

 
   



[top of page]

 
   




[top of page]

   
  


[top of page] 


Last updated October 22, 2020